Literature DB >> 11934579

Neurotrophic activity of honokiol on the cultures of fetal rat cortical neurons.

Yoshiyasu Fukuyama1, Kousuke Nakade, Yuka Minoshima, Ritsuko Yokoyama, Haifeng Zhai, Yasuhide Mitsumoto.   

Abstract

Honokiol, a main biphenyl neolignan of the traditional crude medicine, Magnoliae cortex, was found to show neurotrophic activity on the cultures of rat cortical neurons at concentration from 0.1 to 10 microM. In the cortical neurons cultured in serum-free medium supplemented with B27, honokiol could promote neurite outgrowth. In addition, the survival and growth of neurons were significantly enhanced by adding honokiol to the primary cultures in serum-free medium supplemented with N2. Its neurotrophic activity was comparable to 40 ng mL(-1) of bFGF at concentration of 10 microM.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11934579     DOI: 10.1016/s0960-894x(02)00112-9

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  12 in total

1.  Neurite outgrowth effect of 4-O-methylhonokiol by induction of neurotrophic factors through ERK activation.

Authors:  Yong Kyoung Lee; Im Seop Choi; Young Heui Kim; Ki Ho Kim; Sang Yun Nam; Young Won Yun; Moon Soon Lee; Ki Wan Oh; Jin Tae Hong
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

2.  Honokiol suppresses the development of post-ischemic glucose intolerance and neuronal damage in mice.

Authors:  Shinichi Harada; Maya Kishimoto; Mana Kobayashi; Kazuo Nakamoto; Wakako Fujita-Hamabe; Hwei-Hsien Chen; Ming-Huan Chan; Shogo Tokuyama
Journal:  J Nat Med       Date:  2012-01-20       Impact factor: 2.343

3.  Distinct photoacidity of honokiol from magnolol.

Authors:  Hongmei Li; Xianfeng Wang; Yuzhu Hu
Journal:  J Fluoresc       Date:  2010-09-01       Impact factor: 2.217

4.  Honokiol for the Treatment of Neonatal Pain and Prevention of Consequent Neurobehavioral Disorders.

Authors:  Anna Woodbury; Shan Ping Yu; Dongdong Chen; Xiaohuan Gu; Jin Hwan Lee; James Zhang; Alyssa Espinera; Paul S García; Ling Wei
Journal:  J Nat Prod       Date:  2015-11-05       Impact factor: 4.050

5.  Magnolol Protects against MPTP/MPP(+)-Induced Toxicity via Inhibition of Oxidative Stress in In Vivo and In Vitro Models of Parkinson's Disease.

Authors:  Akiko Muroyama; Aya Fujita; Cheng Lv; Shota Kobayashi; Yoshiyasu Fukuyama; Yasuhide Mitsumoto
Journal:  Parkinsons Dis       Date:  2012-05-08

6.  Honokiol blocks store operated calcium entry in CHO cells expressing the M3 muscarinic receptor: honokiol and muscarinic signaling.

Authors:  Hsiu-Jen Wang; Alexis G Martin; Po-Kuan Chao; Rhett A Reichard; Adam L Martin; Yue-wern Huang; Ming-Huan Chan; Robert S Aronstam
Journal:  J Biomed Sci       Date:  2013-02-23       Impact factor: 8.410

7.  Integrating findings of traditional medicine with modern pharmaceutical research: the potential role of linked open data.

Authors:  Matthias Samwald; Michel Dumontier; Jun Zhao; Joanne S Luciano; Michael Scott Marshall; Kei Cheung
Journal:  Chin Med       Date:  2010-12-17       Impact factor: 5.455

8.  Methyl 3,4-dihydroxybenzoate promotes neurite outgrowth of cortical neurons cultured in vitro.

Authors:  Zheng Zhang; Xing Zhou; Xiaowen Zhou; Xiao Xu; Minjing Liao; Li Yan; Ruohua Lv; Huanmin Luo
Journal:  Neural Regen Res       Date:  2012-05-05       Impact factor: 5.135

9.  Neuritogenic effect of standardized extract of Centella asiatica ECa233 on human neuroblastoma cells.

Authors:  Oraphan Wanakhachornkrai; Varisa Pongrakhananon; Preedakorn Chunhacha; Aree Wanasuntronwong; Anusara Vattanajun; Boonyong Tantisira; Pithi Chanvorachote; Mayuree H Tantisira
Journal:  BMC Complement Altern Med       Date:  2013-08-04       Impact factor: 3.659

Review 10.  Neuro-modulating effects of honokiol: a review.

Authors:  Anna Woodbury; Shan Ping Yu; Ling Wei; Paul García
Journal:  Front Neurol       Date:  2013-09-11       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.